Hemply Balance (HMPLY) Q2 2026 earnings summary

Executive summary

• Revenue for Q2 2026 increased by 491.4% year-over-year to 479 TSEK, and H1 2026 revenue rose 113.3% to 704 TSEK compared to H1 2025.

• Gross margin for H1 2026 was 66.2%, up from 71.7% for the full year 2025.

• Operating loss (EBITDA) for H1 2026 was -196 TSEK, an improvement from -288 TSEK in H1 2025.

• Net loss after tax for H1 2026 was -199 TSEK, compared to -290 TSEK in H1 2025.

• No significant events occurred during or after the second quarter.

Financial highlights

• Q2 2026 net sales: 479 TSEK (Q2 2025: 81 TSEK); H1 2026 net sales: 704 TSEK (H1 2025: 330 TSEK).

• Q2 2026 gross profit: 290 TSEK (Q2 2025: 51 TSEK); H1 2026 gross profit: 466 TSEK (H1 2025: 237 TSEK).

• Q2 2026 EBITDA: -129 TSEK (Q2 2025: -195 TSEK); H1 2026 EBITDA: -196 TSEK (H1 2025: -288 TSEK).

• Q2 2026 net result: -132 TSEK (Q2 2025: -196 TSEK); H1 2026 net result: -199 TSEK (H1 2025: -290 TSEK).

• Equity as of June 30, 2026: 494 TSEK (June 30, 2025: 876 TSEK).

Outlook and guidance

• Strategic focus remains on completing a reverse acquisition or similar transaction within the year.

• Operational uncertainty persists due to payment delays from the Japanese distributor.